... pipeline and geographical presence is attractive. Tamae told CNBC-TV18 that they will explore other options if the 20% open offer does not happen. He staetd that they will make an open offer for ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...Sankyo ... in Ranbaxy Labs at Rs 737/sh, which will also be priced at Rs 737 per share, reports CNBC-TV18. Daiichi's stake buy in Ranbaxy will trigger an open offer. Ranbaxy will make a ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...Sankyo Co.'s purchase of Ranbaxy Laboratories Ltd., the role of generic medicines in treating diseases and drug development in emerging markets. Japanese drugmaker Daiichi Sankyo said it would buy ...
5 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...id Daiichi Sankyo would get 50.1% stake in Ranbaxy. "Ranbaxy will turn into a debt free company post deal. About USD 440 million FCCBs will be converted into equity. The FCCB conversion, new ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Positive comments on Ranbaxy- Daiichi Sankyo deal are seen coming from the market experts. The deal is seen as the first generics-proprietary partnership in global pharma. Udayan Mukherjee, CNBC-TV18 explains that Ranbaxy is the largest pharma...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: